Development and validation of stability indicating RP-HPLC and HPTLC for determination of Niclosamide in bulk and in synthetic mixture

Two simple, specific, sensitive, accurate and precise stability indicating methods were described for quantitative determination of the anthelmintics drug Niclosamide. The first method was high performance liquid chromatographic with the use of a reversed phase hibar^R C-18 column (250 mm × 4.66 mm, 5 μm) and mobile phase of methanol: 1 mM ammonium phosphate buffer (85:15 v/v) at a flow rate of 1.2 mL/min. The retention time of drug was found to be 6.45 ± 0.02 min. Quantification of drug was achieved with diode array detection (DAD) at 332 nm. Linear calibration curve was obtained in concentration range 0.01–100 μg/mL with r² value of 0.999. The limit of detection and limit of quantification were found to be 0.048 μg/mL and 0.01 μg/ml respectively. The second method involved a high performance thin layer liquid chromatographic. Chromatographic separation was carried out with precoated silica gel G60 F254 aluminum sheets using toluene:ethyl acetate (7:3% v/v) as a mobile phase. Linearity of proposed method was found to be 200–700 ng/band at 332 nm with retention factor of 0.59 and r² value of 0.998. The limit of detection and limit of quantification were found to be 36.21 ng/band and 109.7 ng/band respectively. Both the developed methods were successfully validated as per International Conference on Harmonization guideline (ICH). Niclosamide was subjected to different stress conditions. The degraded product peaks were well resolved from the pure drug peak with significant difference in their retention time. Stress samples were successfully assayed by developed high performance liquid chromatographic and high performance thin layer liquid chromatographic method. Statistically analysis proves that there were no statistical significant differences between two developed methods.     

Derivative spectrophotometric analysis of benzophenone (as an impurity) in phenytoin

ABSTRACT: Three simple and rapid spectrophotometric methods were developed for detection and trace determination of benzophenone (the main impurity) in phenytoin bulk powder and pharmaceutical formulations. The first method, zero-crossing first derivative spectrophotometry, depends on measuring the first derivative trough values at 257.6 nm for benzophenone. The second method, zero-crossing third derivative spectrophotometry, depends on measuring the third derivative peak values at 263.2 nm. The third method, ratio first derivative spectrophotometry, depends on measuring the peak amplitudes of the first derivative of the ratio spectra (the spectra of benzophenone divided by the spectrum of 5.0 μg/mL phenytoin solution) at 272 nm. The calibration graphs were linear over the range of 1-10 μg/mL. The detection limits of the first and the third derivative methods were found to be 0.04 μg/mL and 0.11 μg/mL and the quantitation limits were 0.13 μg/mL and 0.34 μg/mL, respectively, while for the ratio derivative method, the detection limit was 0.06 μg/mL and the quantitation limit was 0.18 μg/mL. The proposed methods were applied successfully to the assay of the studied drug in phenytoin bulk powder and certain pharmaceutical preparations. The results were statistically compared to those obtained using a polarographic method and were found to be in good agreement.     

Highly sensitive spectrophotometric methods for the determination, validation and thermogravimetric analysis of antiulcer drugs, nizatidine and ranitidine in pure and pharmaceutical preparations

Two sensitive, simple and rapid UV and second order derivative spectrophotometric methods were developed for the determination of nizatidine and ranitidine hydrochloride in pure form and pharmaceutical preparations. For the first method, UV spectrophotometic method, nizatidine was determined at 325 nm and ranitidine at 325.5 nm with detection limits of 0.07 and 0.04 μg/mL, respectively. For the second method, the distances between two extremum values (peak-to-peak amplitudes), 328/356.5 nm for nizatidine and 326/357 nm for ranitidine were measured in the second order derivative-spectra. The detection limits were found to be 0.02 μg/mL for nizatidine and 0.016 μg/mL for ranitidine, respectively. The thermal analysis of the two drugs was studied by Thermogravimetric Analysis-Differential Scanning Calorimetry (TGA-DSC) techniques. Enthalpy changes were obtained 121.9 and 124.15 J/g for nizatidine and ranitidine, respectively. The proposed method was successfully applied to the analysis of pharmaceutical preparations. The results were in good agreement with those obtained using the reference method; no significant difference were found in the accuracy and precision as revealed by the accepted values of t- and F-tests.     

Spectrofluorimetric Determination of Itraconazole in Dosage Forms and Spiked Human Plasma

A highly sensitive fluorimetric method was developed for the determination of itraconazole in pharmaceutical preparations and biological fluids. The proposed method is based on measuring the native fluorescence intensity of itraconazole in methanol at 380 nm after excitation at 260 nm. The fluorescence intensity‐concentration plot was rectilinear over the range 0.2 to 2.0 μg/mL with a lower detection limit of 0.05 μg/mL (6.52 × 10^?11 M). The method was further applied to the determination of itraconazole in capsules and spiked human plasma, the mean % recoveries (n = 4) was 100.37 ± 0.86 and 95.47 ± 2.93, respectively. The mean % recoveries were in agreement with those obtained from a reference method.     

Validated stability indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity testing

An accurate, simple, sensitive and selective reversed phase liquid chromatographic method has been developed for the determination of ebastine in its pharmaceutical preparations. The proposed method depends on the complexation ability of the studied drug with Zn²⁺ ions. Reversed phase chromatography was conducted using an ODS C18 (150 × 4.6 mm id) stainless steel column at ambient temperature with UV-detection at 260 nm. A mobile phase containing 0.025%w/v Zn²⁺ in a mixture of (acetonitril/methanol; 1/4) and Britton Robinson buffer (65:35, v/v) adjusted to pH 4.2, has been used for the determination of ebastine at a flow rate of 1 ml/min. The calibration curve was rectilinear over the concentration range of 0.3 - 6.0 μg/ml with a detection limit (LOD) of 0.13 μg/ml, and quantification limit (LOQ) of 0.26 μg/ml. The proposed method was successfully applied for the analysis of ebastine in its dosage forms, the obtained results were favorably compared with those obtained by a comparison method. Furthermore, content uniformity testing of the studied pharmaceutical formulations was also conducted. The composition of the complex as well as its stability constant was also investigated. Moreover, the proposed method was found to be a stability indicating one and was utilized to investigate the kinetics of alkaline and ultraviolet induced degradation of the drug. The first-order rate constant and half life of the degradation products were calculated.     

A new sensitive spectrophotometric determination of sodium 2-mercaptoethanesulfonate using leuco xylene cyanol FF

A simple and accurate spectrophotometric method for determination of sodium 2-mercaptoethanesulfonate (MESNa) with leuco xylene cyanol FF (LXCFF) has been developed. The proposed method is based on the reaction of MESNa with potassium iodate(V) in acidic medium to liberate iodine, which oxidizes leuco xylene cyanol FF to its blue form xylene cyanol FF. The xylene cyanol FF dye formed shows maximum and stable absorbance at pH 4.1–4.2. Absorbance of the obtained colored products was measured at 613 nm. The molar absorptivity, limit of detection and limit of determination of the method were found to be 3.64 × 10⁴ L/mol cm, 0.29 and 0.33 μg/mL, respectively. The colour system obeys Beer’s laws in the range 0.4–4.0 μg/mL of MESNa. All the variables were studied in order to optimize the reaction conditions. The procedure was used for determination of MESNa in pharmaceutical preparations. Reliability of determination was confirmed applying standard iodometric method, recommended by European and Polish Pharmacopoeia.     

Determination and purification of sesamin and sesamolin in sesame seed oil unsaponified matter using reversed‐phase liquid chromatography coupled with photodiode array and tandem mass spectrometry and high‐speed countercurrent chromatography

In Asian countries, sesame seed oil unsaponified matter is used as a natural food additive due to its associated antioxidant effects. We determined and purified the primary lignans sesamin and sesamolin in sesame seed oil unsaponified matter using reversed‐phase liquid chromatography coupled with photodiode array and tandem mass spectrometry and high‐speed countercurrent chromatography. Calibration curves showed good correlation coefficients (r² > 0.999, range 0.08 and/or 0.15 to 5 μg/mL) with a limit of detection (at 290 nm) of 0.02 μg/mL for sesamin and 0.04 μg/mL for sesamolin. Sesame seed oil unsaponified matter contained 2.82% sesamin and 2.54% sesamolin, respectively. Direct qualitative analysis of sesamin and sesamolin was achieved using quadrupole mass spectrometry with positive‐mode electrospray ionization. Pure (>99%) sesamin and sesamolin standards were obtained using high‐speed countercurrent chromatographic purification (hexane/ethyl acetate/methanol/water; 7:3:7:3). An effective method for determining and purifying sesamin and sesamolin from sesame seed oil unsaponified matter was developed by combining these separation techniques for standardized food additives.     

Spectrophotometric and Titrimetric Assay of Flutamide in Pharmaceuticals

Three methods, two spectrophotometric and one titrimetric, which are simple, easy to perform and cost-effective, are presented for the determination of flutamide, an anti-cancer drug. In the first spectrophotometric method (method A), absorbance of flutamide solution in methanol was measured at 290 nm. Measurement of absorbance of reduced flutamide (RFAD) in HCl at 245 nm serves as the basis of the second spectrophotometric method (method B). RFAD, in strong HCl medium was titrated vs standard sodium nitrite, determining the end-point potentiometrically (method C). Experimental variables influencing assays were studied and optimized. Beer’s law was obeyed over concentration ranges: 2.5–25.0 and 1.0–9.0 μg/mL for method A and method B, respectively, with molar absorptivity values of 1.0 × 10⁴ and 2.4 × 10⁴ L/(mol cm). Calculated limits of detection and quantification were 0.18 and 0.54 μg/mL (method A) and 0.16 and 0.18 μg/mL (method B). Titration reaction followed a 1: 1 stoichiometry and the method is applicable to 4?30 mg RFAD. Repeatability, reproducibility and accuracy of the methods were satisfactory. The methods were also validated for selectivity, robustness and ruggedness. The developed methods were applied to the determination of active ingredient in tablets, and the results agreed well with the label claim and those of a reference method. Accuracy was also assessed by recovery test via standard–addition procedure. The drug was subjected to different stress conditions, such as acid and base hydrolysis, oxidation and thermolysis and analyzed subsequently by method A, as a part of stress testing. Results indicated that the drug is slightly vulnerable to all stress-conditions studied.     

Simultaneous determination of ten antiepileptic drugs in human plasma by liquid chromatography and tandem mass spectrometry with positive/negative ion‐switching electrospray ionization and its application in therapeutic drug monitoring

A simple, rapid, and high‐throughput liquid chromatography with tandem mass spectrometry method for the simultaneous quantitation of ten antiepileptic drugs in human plasma has been developed and validated. The method required only 10 μL of plasma. After simple protein precipitation using acetonitrile, the analytes and internal standard diphenhydramine were separated on a Zorbax SB‐C₁₈ column (50 × 4.6 mm, 2.7 μm) using acetonitrile/water as the mobile phase at a flow rate of 0.9 mL/min. The total run time was 6 min for each sample. The validation results of specificity, matrix effects, recovery, linearity, precision, and accuracy were satisfactory. The lower limit of quantification was 0.04 μg/mL for carbamazepine, 0.02 μg/mL for lamotrigine, 0.01 μg/mL for oxcarbazepine, 0.4 μg/mL for 10‐hydroxycarbazepine, 0.1 μg/mL for carbamazepine‐10,11‐epoxide, 0.15 μg/mL for levetiracetam, 0.06 μg/mL for phenytoin, 0.3 μg/mL for valproic acid, 0.03 μg/mL for topiramate, and 0.15 μg/mL for phenobarbital. The intraday precision and interday precision were less than 7.6%, with the accuracy ranging between –8.1 and 7.9%. The method was successfully applied to therapeutic drug monitoring of 1237 patients with epilepsy after administration of standard antiepileptic drugs. The method has been proved to meet the high‐throughput requirements in therapeutic drug monitoring.     

Synchronous fluorescence spectrofluorimetric method for the simultaneous determination of metoprolol and felodipine in combined pharmaceutical preparation

A rapid, simple and sensitive synchronous specrtofluorimetric method has been developed for the simultaneous analysis of binary mixture of metoprolol (MTP) and felodipine (FDP). The method is based upon measurement of the synchronous fluorescence intensity of the two drugs at Δλ of 70 nm in aqueous solution. The different experimental parameters affecting the synchronous fluorescence intensities of the two drugs were carefully studied and optimized. The fluorescence intensity-concentration plots were rectilinear over the ranges of 0.5-10 μg/mL and 0.2-2 μg/mL for MTP and FDP, respectively. The limits of detection were 0.11 and 0.02 μg/mL and quantification limits were 0.32 and 0.06 μg/mL for MTP and FDP, respectively. The proposed method was successfully applied for the determination of the two compounds in their commercial tablets and the results obtained were favorably compared to those obtained with a comparison method.     

Flow-injection determination of indole derivatives in pharmaceutical mixtures

The reactions of tryptamine derivatives with 4-chloro-5,7-dinitrobenzofurazan were studied. The composition of the products of analytical reactions was found from the data of elemental analysis, and their structures were confirmed by ¹H NMR spectra. The working conditions were selected for the flow-injection determination of 22 indole derivatives in pharmaceutical mixtures as 5,7-dinitrobenzofurazans with spectrophotometric detection at 490 nm. Optimum results were obtained using acetonitrile-buffer solution (pH 6.8) flows. The analytical range for biologically active substances was between 0.04 and 0.61 μg/mL. The throughput was 25–35 sample/h. The detection limit was 0.01 μg/mL. Serotonin, mexamine, melatonine, sumatryptan, and indolylacetic acid derivatives were determined in pharmaceuticals and in reaction mixtures from the synthesis of biologically active substances.     

Stability-indicating HPLC method for determination of naftazone in tablets. Application to degradation kinetics and content uniformity testing

A simple, sensitive, stability-indicating HPLC method was developed and validated for the quantitative determination of the vasoprotective drug, naftazone in presence of its degradation products. The analysis was carried out on a Nucleosil 100-5 phenyl column (250 mm × 4.6 mm, 5 μm) using a mobile phase consisting of methanol-0.02 M sodium dihydrogen phosphate mixture (60:40, v/v) of pH 6.0. The analyses were performed at ambient temperature with a flow rate of 1.0 mL/min and UV detection at 270 nm. The method showed good linearity over the concentration range of 0.1-10.0 μg/mL with a lower detection limit of 0.032 and quantification limit of 0.096 μg/mL. The suggested method was successfully applied for the analysis of naftazone in its commercial tablets. Moreover, it was utilized to investigate the kinetics of alkaline, acidic and oxidative degradation of the drug. The apparent first-order rate constants, half-life times, and activation energies of the degradation process were calculated. The pH-rate profile curve was derived. Furthermore, the proposed method was successfully applied to the content uniformity testing of naftazone tablets.     

Development of a micellar electrokinetic capillary chromatography method for the determination of four naphthalenediols in cosmetics and a comparison with a HPLC method

A micellar electrokinetic capillary chromatography (MEKC) method with ultraviolet visible (UV) detection was used for the determination of 1,7-naphthalenediol, 2,3-naphthalenediol, 1,5-naphthalenediol, and 2,7-naphthalenediol in cosmetics. The current method for their determination in various cosmetics is high-performance liquid chromatography (HPLC). Separation conditions affecting the MEKC method were optimized as 20 mM Na₂B₄O₇–50mM SDS, pH 9.8, with 22 kV applied voltage and UV detection at 230 nm. Under optimal conditions, electrophoretic analysis was completed in less than 6 min, with limit of detection (LOD) of 0.070–0.19 μg/mL and limit of quantitation (LOQ) of 0.23–0.63 μg/mL. A good linear relationship (r² > 0.99) was obtained at the range of 0.75–20 μg/mL. Recoveries for the four naphthalenediols in lotion, loose powder, and sun cream are between 91.2–107.2% with relative standard deviation (RSD) less than 4.04%. The method has been successfully applied to the determination of the four naphthalenediols in different kinds of cosmetics. A comparison with HPLC-UV method was also carried out according to the National Standards of the People's Republic of China. The results obtained by MEKC and HPLC methods are comparable, but the proposed MEKC method can help us obtain a much shorter detection time and low cost.     

A validated stability‐indicating ultra performance liquid chromatography method for the determination of potential process‐related impurities in eplerenone

A simple, sensitive, and accurate stability‐indicating analytical method has been developed and validated using ultra high performance liquid chromatography. The developed method is used to evaluate the related substances of eplerenone (EP). The degradation behavior of EP under stress conditions was determined, and the major degradants were identified by ultra high performance liquid chromatography with tandem mass spectrometry. The chromatographic conditions were optimized using an impurity‐spiked solution, and the samples, generated from forced degradation studies. The resolution of EP, its potential impurities, and its degradation products was performed on a Waters UPLC BEH C₁₈ column (50 × 2.1 mm, 1.7 μm) by linear gradient elution using a mobile phase consisting of 10 mmol/L ammonium acetate adjusted to pH 4.5, methanol and acetonitrile. A photo‐diode array detector set at 245 nm was used for detection. The flow rate was set at 0.3 mL/min. The procedure had good specificity, linearity (0.02–3.14 μg/mL), recovery (96.1–103.9%), limit of detection (0.01–0.02 μg/mL), limit of quantitation (0.03–0.05 μg/mL), and robustness. The correction factors of the process‐related substances were calculated.     

Spectrofluorimetric determination of cephradine in commercial formulation using ethylacetoacetate-formaldehyde as fluorogenic agent

A simple, precise and sensitive spectrofluorimetric method was developed for the determination of cephradine in pharmaceutical formulations. The method is based on reaction of cephradine with ethyl acetoacetate (EAA) in the presence of formaldehyde in acidic media. The fluorescence intensity of the resultant fluorescent derivative was measured at 443 nm after excitation at 350 nm. The effects of various experimental parameters on the formation of the fluorescent product were studied and optimized. A linear relationship between concentration of cephradine and fluorescence intensity was found over the range of 0.1–5.0 μg/mL. The limit of detection and quantification were calculated an found 1.09 × 10^?2 ± 3.64 × 10^?3 μg/mL and 3.64 × 10^?2 ± 3.64 × 10^?3 μg/mL, respectively and with relative standard deviation (RSD) 4.14%. Accuracy of the method was checked by standard addition method and applied to four different commercial formulations. The percentage recovery was found in the range of 97.03 to 103.80% for Velora suspension, 98.16 to 102.90% for velocef injection, 99.00 to 108.10% for Velora capsule and 99.06 to 104.90% for Cefradin capsule. The good percentage recoveries from all samples indicated that there were no interferences from the common excipients of formulations. The proposed method was successfully applied to the analysis of commercial suspension, capsule and injections. The result obtained by the proposed method was statistically validated with reference HPLC method. No significant difference in the results of the two methods was found regarding accuracy and precision using Student’s t-test and the variance ratio F-test.     

Kinetic and Spectrophotometric Determination of Thioctic Acid in Bulk and Pharmaceutical Formulations

Three simple and sensitive spectrophotometric methods were developed for the determination of thioctic acid in bulk and in its pharmaceutical preparations using iron(III) as an oxidizing agent. Method A is based on kinetic investigation of oxidation reaction of the drug with iron(III) and a subsequent chelation of the produced iron(II) with ferricyanide to form prussian blue colored product at room temperature for a fixed time of 15 minutes at 750 nm. Methods B and C are based on oxidation of the studied drug with iron(III). The equivalent iron(II) produced is allowed to react with either o‐phenanthroline or bipyridyl to give colored species measurable at 510, 522 nm, respectively. Regression analysis of Beer‐Lambert plots showed a good correlation in the concentration ranges of 0.4–4 μg/mL with a detection limit of 0.095 μg/mL for method A and 0.5–5 μg/mL with detection limits 0.137 and 0.127 for method B and C, respectively. The three methods were successfully applied for the determination of the drug in its dosage forms. The percentage recoveries were 99.88 ± 1.40, 99.98 ± 1.26 and 100.64 ± 1.07, respectively.     

Simple and Sensitive Extractive Spectrophotometeric Method for the Assay of Mebeverine Hydrochloride in Pure and Pharmaceutical Formulations

Simple, sensitive, rapid and cost effective extraction spectrophotometric methods are described for the assay of mebeverine hydrochloride (MBH) in bulk samples and pharmaceutical formulations. These two methods (Bromophenol blue and Erichrome Black‐T) are based on the formation of chloroform soluble ion‐pair complexes of MBH with Bromophenol blue (BPB) and with Erichrome Black‐T (EBT), to form yellow and pink colored chromogen in a Glycine‐HCl buffer of pH 2.4 (BPB) and in a KCl‐HCl buffer of pH 1.4 (EBT) with absorbance maximum at 416 nm and at 524 nm for BPB and EBT respectively. The calibration graph is found to linear over 0.2–20 μg/mL (BPB) and 0.2–20 μg/mL (EBT), with molar absorptivity values of 1.8295 × 10⁴ 1 moL^?1 cm^?1 and 1.5896 × 10⁴ 1 moL^?1 cm^?1, respectively. The LOD (Limit of Detection) were found to be 0.090 μg/mL and 0.084 μg/mL and LOQ (Limit of Quantification) were 0.2997 μg/mL and 0.2730 μg/mL for the BPB and EBT method, respectively. The results of analysis for the two methods have been validated statistically and by recovery studies. The results are compared with those obtained with reported method. The proposed methods are simple, sensitive, accurate and suitable for quality control applications.     

Spectrophotometric Determination of L-Ascorbic Acid Based on Its Oxidation by Potassium Peroxodisulfate in the Presence of Cu(II) as Catalyst

A new, selective and accurate direct spectrophotometric procedure was developed for the determination of L-ascorbic acid (AA) in pharmaceuticals. Background correction was based on the oxidation of AA by potassium peroxodisulfate in the presence of Cu(II) as a catalyst. The molar absorptivity of the proposed procedure was 1.04 × 10⁴ L/(mol cm) at 262 nm. Beer’s law was obeyed in the concentration range of 0.68–16.00 μg/mL for AA. The detection limit was 0.20 μg/mL, and the relative standard deviation was 0.91% (n = 7) for 8.00 μg/mL AA. Other compounds commonly found in pharmaceutical preparations did not interfere with the detection of AA. The proposed procedure was successfully applied to the determination of AA in pharmaceuticals, and the results obtained agreed with those obtained by iodine titration.     

Kinetic Spectrophotometric Determination of Ranitidine

Two spectrophotometric methods were developed for the determination of ranitidine. The first method was a kinetic spectrophotometric method based on the catalytic effect of ranitidine on the reaction between sodium azide and iodine in an aqueous solution. The calibration graph was linear from 4–24 μg/mL. The drug was determined by measuring the decrease in the absorbance of iodine at 348 nm using a fixed time method. The decrease in the absorbance after 1 minute from the initiation of the reaction was related to the concentration of drug. The detection limit of the procedure was 0.76 μg/mL. The proposed procedure was successfully utilized in the determination of the drug in pharmaceutical preparations with mean recovery in the range of 99.83 ? 101.16%. The second method is a colorimetric method, which depends on the measurement of absorbances of tris (o‐phenanthroline) iron(II) [method 2A] and tris (bipyridyl) iron(II) [method 2B] complexes at 512 nm. The complexes obeyed Beer's law over the concentration range of 2–16 μg/mL and 4–40 μg/mL for methods 2A and 2B, respectively. The developed method has been successfully applied for the determination of ranitidine in bulk drugs and pharmaceutical formulations. The common excipients and additives did not interfere in its determination.